Case EvaluationQualify your case in
just 5 minutes.
In 2002 the patent protection held by Hoffman-LaRoche for Accutane expired and several other manufacturers entered the acne treatment market selling generic versions of Accutane. One of these brands is Amnesteem, a generic version of Accutane manufactured by Bertek Pharmaceuticals Inc.
Experts believe the risk of developing Inflammatory Bowel Disease (IBD), Crohn’s Disease and Ulcerative Colitis is just as strong with Amnesteem as with Accutane.
Roche discontinued production and sales of Accutane on June 29, 2009 citing, among other things, poor market share. They estimated that by the time it was taken off the market, Accutane only represented 5% of the market due to the increased popularity of the cheaper generic versions.
If you were prescribed Amnesteem or another generic version of Accutane and are now experiencing any symptoms related to IBD, Crohn’s Disease or Ulcerative Colitis, you may be entitled to an award for your damages and suffering. Contact us today for a confidential evaluation of your case.